Craft

Advanced
Stalicla

Stalicla

Total Funding

$18.2 M

Stalicla Summary

Company Summary

Overview
Stalicla is a biotechnology company developing precision medicine treatments for patients with neurodevelopmental disorders. Its drug discovery platform characterizes biologically similar subgroups of patients with autism spectrum disorder and identifies tailored treatments.
Type
Private
Status
Active
Founded
2017
HQ
Genève, CH | view all locations
Website
https://stalicla.com/
Cybersecurity rating
Sectors

Table of Contents

Key People

  • Guillaume Pfefer

    Guillaume Pfefer, Board Member

    • Lynn Durham

      Lynn Durham, CEO, Founder, Board Member

      LocationsView all

      1 location detected

      • Genève, GE HQ

        Switzerland

        Avenue de Sécheron 15

      Competitors and Similar Companies

      Compare competitors

      Footer menu

      Product

      Solutions

      Resources

      Company

      © Craft.co 2026
      Share price data provided by IEX